Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third quarter of 2025. The new ...

Build the skills, strategy and credibility to lead AI transformation AI is disrupting every sector, but most professionals lack the clarity and confidence to lead it. The LSE AI Leadership Accelerator ...

The UAB Heersink SOM MSTP provides a truly integrated MD-PhD training program for aspiring physician scientists. During the first 2-years of the program, our students take both a selection of medical ...